Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Interest & Investment Income (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Interest & Investment Income data on record, last reported at $2.2 million in Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 10.76% to $2.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.0 million, a 71.1% increase, with the full-year FY2025 number at $11.3 million, up 165.13% from a year prior.
  • Interest & Investment Income reached $2.2 million in Q1 2026 per TECX's latest filing, down from $2.6 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for TECX hit a ceiling of $3.4 million in Q2 2025 and a floor of -$370000.0 in Q1 2022.
  • A 5-year average of $1.1 million and a median of $256000.0 in 2024 define the central range for Interest & Investment Income.
  • On a YoY basis, Interest & Investment Income climbed as much as 5450.0% in 2022 and fell as far as 3800.0% in 2022.
  • Tracing TECX's Interest & Investment Income over 5 years: stood at $245000.0 in 2022, then tumbled by 45.71% to $133000.0 in 2023, then soared by 1204.51% to $1.7 million in 2024, then soared by 47.78% to $2.6 million in 2025, then dropped by 14.94% to $2.2 million in 2026.
  • Business Quant data shows Interest & Investment Income for TECX at $2.2 million in Q1 2026, $2.6 million in Q4 2025, and $2.9 million in Q3 2025.